Michael Smith

Search results

• Insmed Compendium - A Snapshot as of March 31, 2024

  Smith, M.

  4/1/24

  2 items of Media coverage

  Press/Media: Press / Media

• Insmed Compendium - A Snapshot as of March 31, 2024

  Smith, M.

  4/1/24

  2 items of Media coverage

  Press/Media: Press / Media

• Monthly: Insmed (INSM: $27.13) tumbles 6% on average volume in March 2024

  Smith, M.

  3/28/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Insmed (INSM: $27.72) increases, beating 81% of stocks

  Smith, M.

  3/4/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Insmed (INSM: $27.72) increases, beating 81% of stocks

  Smith, M.

  3/1/24

  1 item of Media coverage

  Press/Media: Press / Media

• Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States

  Smith, M.

  2/29/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Insmed (INSM: $27.72) increases, beating 81% of stocks

  Smith, M.

  2/29/24

  1 item of Media coverage

  Press/Media: Press / Media

• JOHN LOTHIAN NEWSLETTER DAILY UPDATE PODCAST – 2/5/2024

  Smith, M.

  2/7/24

  1 item of Media coverage

  Press/Media: Press / Media

• Big tech is about to change the stock market forever

  Smith, M.

  2/5/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Insmed (INSM: $27.80) plummets 7% on firm volume in January 2024

  Smith, M.

  2/5/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Xenon Pharmaceuticals (XENE: $45.22) increases, beating 85% of stocks

  Smith, M.

  2/5/24

  1 item of Media coverage

  Press/Media: Press / Media

• Area students named to SUNY Potsdam President's List

  Smith, M.

  2/1/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Insmed (INSM: $27.80) falls 7% on firm volume in January 2024

  Smith, M.

  2/1/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Xenon Pharmaceuticals (XENE: $45.22) increases, beating 85% of stocks

  Smith, M.

  2/1/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Insmed (INSM: $27.80) plummets 7% on firm volume in January 2024

  Smith, M.

  1/31/24

  1 item of Media coverage

  Press/Media: Press / Media

• Monthly: Xenon Pharmaceuticals (XENE: $45.22) increases, beating 85% of stocks

  Smith, M.

  1/31/24

  1 item of Media coverage

  Press/Media: Press / Media

• 24 unwound, canceled hospital deals

  Smith, M.

  1/30/24

  1 item of Media coverage

  Press/Media: Press / Media

• GLANCING BACK

  Smith, M.

  1/20/24

  1 item of Media coverage

  Press/Media: Press / Media

• Glancing Back for Jan 20: Man confesses to fatal hit-and-run

  Smith, M.

  1/20/24

  1 item of Media coverage

  Press/Media: Press / Media

• Glancing Back for Jan 20: Man confesses to fatal hit-and-run

  Smith, M.

  1/20/24

  1 item of Media coverage

  Press/Media: Press / Media

• Weekly: Xenon Pharmaceuticals (XENE: $45.09) decreases 0.9% on firm volume; -41c [0.9%] Vol Index 1.3 [1 is avg]

  Smith, M.

  1/16/24

  1 item of Media coverage

  Press/Media: Press / Media

• Paid Obits

  Smith, M., Thompson, M. & Smith, B.

  1/13/24

  1 item of Media coverage

  Press/Media: Press / Media

• Weekly: Xenon Pharmaceuticals (XENE: $45.09) decreases 0.9% on firm volume; -41c [0.9%] Vol Index 1.3 [1 is avg]

  Smith, M.

  1/13/24

  1 item of Media coverage

  Press/Media: Press / Media

• Sunburn — The morning read of what's hot in Florida politics — 1.11.24

  Smith, M.

  1/11/24

  1 item of Media coverage

  Press/Media: Press / Media

• Weekly: Xenon Pharmaceuticals (XENE: $45.50) shares post worst week in eight weeks; -56c [1.2%] Vol Index 1.5 [1 is avg]

  Smith, M.

  1/8/24

  1 item of Media coverage

  Press/Media: Press / Media